Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System ...
On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...
Discover Avala Hospital's first-ever FDA-approved cataract lens for improved vision and quality of life in Covington, La.
At the 2026 ASCRS Annual Meeting in Washington, DC, several presentations converged on a set of questions that define the ...
Mahajan Eye Centre, a trusted name in advanced eye care in Delhi, has launched a public awareness initiative to educate ...
Johnson & Johnson MedTech reported 4.6% growth in Q1, driven by a strong pipeline of cardiovascular and surgical innovations.
Omaha, Nebraska, April 14, 2026 (GLOBE NEWSWIRE) -- Omaha, Nebraska - April 14, 2026 - - ...
Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...
Opinion
4don MSNOpinion
Mitchells Plain, Soweto, and Nobody: unpacking the economic challenges through the Lehohla Ledger
The Lehohla Ledger serves as a vital diagnostic tool, revealing the economic challenges faced by Mitchell's Plain, Soweto, and Nobody. This analysis explores the systemic issues affecting these areas ...
Johnson & Johnson will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of Cataract and ...
Alcon launched its Clareon TruPlus enhanced monofocal and toric IOLs in the U.S., according to a press release.The lens ...
Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results